Who owns Bridgebio Pharma Inc?
- Ticker: BBIO
- CUSIP Number: 10806x102
Tip: Access positions for across all investors
Analyze quarterly positions in Bridgebio Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Bridgebio Pharma stock
Who bought or sold Bridgebio Pharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 17M | $1.3B | 0% | Dec 2025 |
|
| BlackRock | 14M | $1.1B | -2% | Mar 2026 |
|
| Kohlberg Kravis Roberts & Co | 13M | $985M | 0% | Mar 2026 |
|
| Henderson Group | 13M | $979M | 51% | Mar 2026 |
|
| Viking Global Investors | 12M | $879M | -18% | Mar 2026 |
|
| Farallon Capital Management | 9.0M | $688M | 10% | Dec 2025 |
|
| Vanguard Portfolio Management | 8.1M | $600M | 100% | Mar 2026 |
|
| Vanguard Capital Management | 7.8M | $576M | 100% | Mar 2026 |
|
| UBS Group | 5.9M | $437M | 3% | Mar 2026 |
|
| Aisling Capital Management | 5.1M | $378M | 0% | Mar 2026 |
|
| State Street Corporation | 5.0M | $380M | -11% | Dec 2025 |
|
| Jane Street | 4.9M | $367M | 27% | Mar 2026 |
|
| Geode Capital Management | 4.9M | $373M | 11% | Mar 2026 |
|
| Invesco | 4.6M | $341M | -5% | Mar 2026 |
|
| Susquehanna International | 3.7M | $284M | -9% | Dec 2025 |
|
| Frazier Life Sciences Management | 3.4M | $256M | -3% | Mar 2026 |
|
| Citadel Advisors | 3.4M | $252M | 170% | Mar 2026 |
|
| Two Sigma Investments | 3.1M | $232M | 60% | Mar 2026 |
|
| D. E. Shaw & Co | 2.5M | $189M | 15% | Mar 2026 |
|
| Franklin Resources | 2.4M | $181M | 13% | Mar 2026 |
|
| FMR | 2.4M | $183M | 41% | Dec 2025 |
|
| Wellington Management Company | 2.3M | $180M | 130% | Dec 2025 |
|
| Manufacturers Life Insurance Company | 2.0M | $147M | 0% | Mar 2026 |
|
| Charles Schwab Investment Management | 2.0M | $150M | 2% | Dec 2025 |
|
| Goldman Sachs Group | 2.0M | $145M | 1% | Mar 2026 |
|
| Alliancebernstein | 1.9M | $146M | -7% | Mar 2026 |
|
| Morgan Stanley | 1.9M | $139M | 34% | Mar 2026 |
|
| Sc Us | 1.9M | $142M | 0% | Dec 2025 |
|
| Driehaus Capital Management | 1.7M | $129M | 1% | Dec 2025 |
|
| Nomura Asset Management International | 1.5M | $114M | 100% | Mar 2026 |
|
| Laurion Capital Management | 1.4M | $107M | -20% | Dec 2025 |
|
| Pictet Asset Management Holding SA | 1.4M | $102M | 9% | Mar 2026 |
|
| Northern Trust | 1.3M | $103M | -4% | Dec 2025 |
|
| Principal Financial Group | 1.3M | $99M | 1% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 1.3M | $97M | -18% | Mar 2026 |
|
| Polar Capital Holdings | 1.3M | $99M | 32% | Dec 2025 |
|
| Bank of America Corporation | 1.3M | $96M | 100% | Mar 2026 |
|
| Hood River Capital Management | 1.3M | $96M | 1% | Dec 2025 |
|
| Ameriprise Financial | 1.2M | $93M | 48% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 1.2M | $87M | 100% | Mar 2026 |
|
| American Century Companies | 1.1M | $85M | 3% | Dec 2025 |
|
| Lord, Abbett & Co | 1.0M | $76M | 31% | Mar 2026 |
|
| Citigroup | 973k | $72M | 100% | Mar 2026 |
|
| Jennifer Ranahan | 963k | $72M | 54% | Mar 2026 |
|
| ClearBridge Advisors | 951k | $71M | 91% | Mar 2026 |
|
| Allspring Global Investments Holdings | 889k | $66M | -11% | Mar 2026 |
|
| Cormorant Asset Management | 850k | $63M | -29% | Mar 2026 |
|
| Deep Track Capital | 841k | $63M | 4% | Mar 2026 |
|
| Ensign Peak Advisors | 837k | $62M | -34% | Mar 2026 |
|
| Frontier Capital Management | 826k | $63M | 25% | Dec 2025 |
|
| Summit Partners Public Asset Management | 814k | $62M | 1% | Dec 2025 |
|
| Capital Research Global Investors | 764k | $57M | -61% | Mar 2026 |
|
| PanAgora Asset Management | 742k | $55M | 0% | Mar 2026 |
|
| Barclays | 643k | $49M | -13% | Dec 2025 |
|
| Millennium Management | 633k | $47M | 1631% | Mar 2026 |
|
| First Turn Management | 596k | $46M | 1% | Dec 2025 |
|
| Federated Investors | 588k | $44M | 0% | Mar 2026 |
|
| Bank of New York Mellon | 577k | $43M | -3% | Mar 2026 |
|
| PRIMECAP Management Company | 569k | $42M | 0% | Mar 2026 |
|
| Nuveen | 563k | $42M | 14% | Mar 2026 |
|
| Dimensional Fund Advisors | 562k | $42M | 47% | Mar 2026 |
|
| Squarepoint Ops | 556k | $41M | 98% | Mar 2026 |
|
| Ing Investment Management | 539k | $40M | -8% | Mar 2026 |
|
| Diamant Asset Management | 527k | $527M | 100% | Mar 2026 |
|
| Emerald Advisers | 515k | $38M | -4% | Mar 2026 |
|
| Adage Capital Partners GP | 508k | $39M | -46% | Dec 2025 |
|
| Gilder, Gagnon, Howe & Co | 458k | $35M | -1% | Dec 2025 |
|
| Nomura Holdings | 432k | $32M | -19% | Mar 2026 |
|
| Catalio Capital Management | 432k | $32M | 100% | Mar 2026 |
|
| Voloridge Investment Management | 427k | $32M | -33% | Mar 2026 |
|
| Caption Management | 425k | $33M | 70% | Dec 2025 |
|
| Diadema Partners | 410k | $31M | 212% | Dec 2025 |
|
| Sofinnova Ventures | 409k | $30M | -43% | Mar 2026 |
|
| Ubs Global Asset Management Americas | 403k | $30M | -11% | Mar 2026 |
|
| Eventide Asset Management | 362k | $28M | -38% | Dec 2025 |
|
| Russell Investments | 352k | $26M | -15% | Mar 2026 |
|
| Fisher Investments | 352k | $26M | 51% | Mar 2026 |
|
| Balyasny Asset Management | 350k | $26M | 4% | Mar 2026 |
|
| First Trust Advisors | 340k | $25M | 21% | Mar 2026 |
|
| Fiera Capital Corporation | 323k | $24M | 100% | Mar 2026 |
|
| Emerald Mutual Fund Advisers, Trust | 320k | $24M | 1% | Mar 2026 |
|
| Affinity Asset Advisors | 320k | $25M | 392% | Dec 2025 |
|
| Partner Fund Management | 307k | $23M | -6% | Dec 2025 |
|
| Woodline Partners | 301k | $22M | 0% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 297k | $22M | -22% | Mar 2026 |
|
| Sei Investments | 288k | $21M | 28% | Mar 2026 |
|
| Swiss National Bank | 286k | $21M | 1% | Mar 2026 |
|
| Legal & General Group | 285k | $21M | -15% | Mar 2026 |
|
| Nicholas Investments Partners | 285k | $22M | 5% | Dec 2025 |
|
| Algert Coldiron Investors | 284k | $21M | -17% | Mar 2026 |
|
| Candriam Luxembourg S.C.A. | 279k | $21M | 0% | Mar 2026 |
|
| Victory Capital Management | 277k | $21M | -42% | Dec 2025 |
|
| Eagle Health Investments | 267k | $20M | 3% | Mar 2026 |
|
| Bridgewater Associates | 260k | $19M | 501% | Mar 2026 |
|
| Artisan Partners Limited Partnership | 254k | $19M | -9% | Mar 2026 |
|
| CalPERS | 254k | $19M | 22% | Mar 2026 |
|
| Advisor Group Holdings | 252k | $19M | -3% | Dec 2025 |
|
| Sphera Funds Management | 245k | $18M | 128% | Mar 2026 |
|
| Walleye Trading Advisors | 245k | $18M | 580% | Mar 2026 |
|
| Skandinaviska Enskilda Banken AB | 238k | $18M | 60% | Dec 2025 |
|
| SEB Asset Management AB | 236k | $18M | 100% | Mar 2026 |
|
| Royce & Associates | 233k | $17M | 0% | Mar 2026 |
|
| Boone Capital Management | 229k | $17M | 24% | Mar 2026 |
|
| Neuberger Berman Group | 221k | $17M | 1% | Dec 2025 |
|
| Nan Fung Trinity | 219k | $16M | 99% | Mar 2026 |
|
| Ikarian Capital | 219k | $16M | 100% | Mar 2026 |
|
| Rhumbline Advisers | 206k | $15M | -4% | Mar 2026 |
|
| Axiom International Investors | 200k | $15M | -4% | Mar 2026 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 200k | $15M | -15% | Mar 2026 |
|
| Portman Square Capital | 194k | $14M | 4% | Mar 2026 |
|
| Erste Asset Management GmbH | 190k | $13M | 72% | Mar 2026 |
|
| Mizuho Markets Americas | 171k | $13M | 6% | Mar 2026 |
|
| WCM Investment Management | 168k | $12M | -4% | Mar 2026 |
|
| Hillsdale Investment Management | 168k | $13M | 2% | Mar 2026 |
|
| California State Teachers Retirement System | 166k | $12M | 24% | Mar 2026 |
|
| New York State Common Retirement Fund | 162k | $12M | 72% | Mar 2026 |
|
| AQR Capital Management | 160k | $12M | 19% | Mar 2026 |
|
| Lazard Asset Management | 143k | $11M | 160% | Mar 2026 |
|
| Royal Bank of Canada | 142k | $11M | -58% | Mar 2026 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 140k | $10M | 54% | Mar 2026 |
|
| TD Asset Management | 137k | $10M | -5% | Mar 2026 |
|
| SG Americas Securities | 134k | $10M | 68% | Mar 2026 |
|
| Vanguard Asset Management | 134k | $9.9M | 100% | Mar 2026 |
|
| Wells Fargo & Company | 133k | $9.8M | -43% | Mar 2026 |
|
| Toroso Investments | 130k | $9.5M | 502% | Mar 2026 |
|
| Rock Springs Capital Management | 128k | $9.5M | 24% | Mar 2026 |
|
| Fred Alger Management | 127k | $9.4M | -38% | Mar 2026 |
|
| Creative Planning | 120k | $8.9M | 8% | Mar 2026 |
|
| Raymond James Financial | 118k | $9.0M | 10% | Dec 2025 |
|
| Prudential Financial | 115k | $8.6M | -16% | Mar 2026 |
|
| Qube Research & Technologies | 114k | $8.7M | -70% | Dec 2025 |
|
| Tema Etfs | 112k | $8.3M | 35% | Mar 2026 |
|
| HealthInvest Partners AB | 111k | $12M | -21% | Mar 2026 |
|
| Mackenzie Financial | 107k | $7.9M | 96% | Mar 2026 |
|
| Granahan Investment Management | 102k | $7.8M | -37% | Dec 2025 |
|
| DekaBank Deutsche Girozentrale | 100k | $7.1M | 0% | Mar 2026 |
|
| Envestnet Asset Management | 100k | $7.4M | 223% | Mar 2026 |
|
| ADAR1 Capital Management | 94k | $7.0M | -56% | Mar 2026 |
|
| Voleon Capital Management | 94k | $7.0M | 74% | Mar 2026 |
|
| State of Wisconsin Investment Board | 91k | $7.0M | 0% | Dec 2025 |
|
| Rhenman & Partners Asset Management AB | 91k | $6.7M | 11% | Mar 2026 |
|
| Knott David M Jr | 90k | $6.7M | 6% | Mar 2026 |
|
| EFG International | 88k | $6.7M | 100% | Dec 2025 |
|
| MetLife Investment Advisors | 88k | $6.7M | -4% | Dec 2025 |
|
| Leucadia National Corporation | 82k | $6.1M | -59% | Mar 2026 |
|
| CastleArk Management | 82k | $6.1M | -28% | Mar 2026 |
|
| Brevan Howard Capital Management | 82k | $6.1M | -53% | Mar 2026 |
|
| Exome Asset Management | 81k | $6.2M | -39% | Dec 2025 |
|
| HighVista Strategies | 80k | $6.1M | -2% | Dec 2025 |
|
| Rafferty Asset Management | 80k | $6.1M | -47% | Dec 2025 |
|
| Moody Aldrich Partners | 76k | $5.6M | -42% | Mar 2026 |
|
| Marshall Wace | 75k | $5.7M | -26% | Dec 2025 |
|
| Cinctive Capital Management | 70k | $5.4M | -27% | Dec 2025 |
|
| Monashee Investment Management | 67k | $5.0M | -33% | Mar 2026 |
|
| HighTower Advisors | 48k | $3.5M | -48% | Mar 2026 |
|
| Eudaimonia Asset Management | 31k | $2.3M | -67% | Mar 2026 |
|
| Prosight Management | 30k | $2.3M | -89% | Dec 2025 |
|
Who sold out of Bridgebio Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Macquarie Group | Sep 2025 | 1.9M | $100M |
| Norges Bank Investment Management | Dec 2025 | 1.5M | $117M |
| Two Sigma Advisers | Dec 2025 | 1.4M | $107M |
| T. Rowe Price Investment Management | Sep 2025 | 1.1M | $55M |
| Paradigm Biocapital Advisors | Dec 2025 | 684k | $52M |
| Renaissance Technologies | Sep 2025 | 322k | $17M |
| Jpmorgan Chase & Co | Sep 2025 | 294k | $15M |
| Philosophy Capital Management | Dec 2025 | 200k | $15M |
| LMR Partners | Dec 2025 | 144k | $11M |
| ExodusPoint Capital Management | Dec 2025 | 125k | $9.6M |
| Freestone Grove Partners | Dec 2025 | 125k | $9.6M |
| Arrowpoint Asset Management | Dec 2025 | 110k | $8.4M |
| Mirae Asset Securities | Dec 2025 | 104k | $7.9M |
| Graham Capital Management | Dec 2025 | 101k | $7.7M |
| Superstring Capital Management | Sep 2025 | 89k | $4.6M |
| Susquehanna Fundamental Investments | Sep 2025 | 86k | $4.5M |
| NEOS Investment Management | Dec 2025 | 84k | $6.5M |